DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein tyrosine kinases (PTKs) regulate biological processes, while protein tyrosine phosphatases (PTPs) counteract them.
• PTPs are underrepresented as drug targets due to catalytic domain homology, particularly atypical dual-specificity phosphatases (ADUSPs).
• Dual-specificity phosphatase 3 (DUSP3), also known as VH1-related phosphatase (VHR), is an uncommon regulator of mitogen-activated protein kinase (MAPK) phosphorylation.

Purpose of the Study:

• To review the gene cloning, crystallographic structure, substrates, and biological functions of DUSP3.
• To explore DUSP3's roles in cancer, immune response, thrombosis, hemostasis, angiogenesis, and genomic stability.
• To update knowledge on DUSP3/VHR-inhibiting compounds as potential therapeutic agents.

Main Methods:

• Literature review of DUSP3 research.
• Analysis of gene cloning and crystallographic data.
• Compilation of information on DUSP3 substrates and biological activities.

Main Results:

• DUSP3 exhibits diverse functions, acting as a tumor suppressor or promoter in various cancers.
• DUSP3 influences MAPK-dependent and independent pathways in immune response, hemostasis, and angiogenesis.
• Characterization of DUSP3 substrates and inhibitors is advancing, paving the way for drug development.

Conclusions:

• DUSP3 is a significant enzyme with broad biological relevance and therapeutic potential.
• Further research into DUSP3 substrates and inhibitors is essential for clinical applications.
• DUSP3-targeting drugs may offer novel treatment strategies for human diseases, including cancer.